Zurueck zur Suche

Reporte zur Charge UT7716JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 WI 3 NH 1 ND 1 DC 1 IL 1 NJ 1

VAERS 2608290

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

moderat
Staat
MI
Alter
55,0
Geschlecht
M
Eingang
03.04.2023
Impfdatum
28.03.2023
Beginn
28.03.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cardiovascular evaluation Chest pain Hypoaesthesia

Symptomtext

Associate began feeling numbness in left arm and chest pain later in the day after vaccine. Sought care at the ER for cardiac workup.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2563306

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

moderat
Staat
NH
Alter
1,1
Geschlecht
F
Eingang
19.01.2023
Impfdatum
05.01.2023
Beginn
06.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Full blood count abnormal Granulocyte count Haematocrit normal Haemoglobin normal Hypotonia Influenza A virus test negative Influenza B virus test Lethargy Mean platelet volume decreased Mobility decreased Pyrexia Red cell distribution width increased Vomiting Weight bearing difficulty

Symptomtext

Mother reported vomiting Friday 1/6/2023 and Saturday, 1/7/2023; mother reported patient was fine on Sunday, 1/8/2023; mother reported a fever and decreased movement starting Monday 1/9/2023 office visit - difficulty bearing weight, fever. Thursday, 1/12/2023: Lethargic, difficulty bearing weight and hypotonia lower extrementies - remains on antipyretics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
5,0
Labordaten
Influenza A/B Test - Negative CBC: Granulocytes: 9.4; Hemoglobin: 10.9; Hematocrit: 34.8; RDW 15.7; MPV: 6.2
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2531470

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

mild
Staat
WI
Alter
35,0
Geschlecht
F
Eingang
14.12.2022
Impfdatum
13.10.2022
Beginn
17.10.2022
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Malaise Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

I had received a flu shot on October 13. A few days later, I started having symptoms for what turned out to be COVID-19 (sore throat on ~10/17, followed by runny nose; first positive test ~10/20). This would be considered a breakthrough case given my COVID vaccinations on 4/6/21, 4/30/21, 11/12/21, and 9/12/22. Given that I was barely a month past my latest COVID booster vaccination date, healthcare professionals said it was unexpected that I suffered from COVID, and recommended I report this in case the flu vaccine somehow makes immune systems temporarily more susceptible to developing sickness from exposure to other pathogens.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
first positive COVID rapid test ~10/20/2022
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
undisclosed
Allergien
-
Vorherige Impfungen
-

VAERS 2469791

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

mild
Staat
MI
Alter
53,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
28.09.2022
Beginn
29.09.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Blister Glossodynia Pain Tongue blistering

Symptomtext

Associate notified this nurse that after receiving the influenza vaccine on 09/28/2022, associate woke up with a painful blister on her tongue and on her chin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464485

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

mild
Staat
MI
Alter
55,0
Geschlecht
F
Eingang
29.09.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Feeling hot Injection site erythema Pain Pruritus

Symptomtext

Redness increasing down arm distal from injection site into axillae, itching, warmth, pain. Injection was given at approx 0950am reaction started approx. 1055am. Associate had no s/s of anaphylaxis, benadryl 50mg given orally, ice was placed at injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Type 2 Diabetic, Hypertension, and high cholesterol
Andere Medikamente
Metformin, Simvastatin, enalapril, cetirizine, potassium, and diclofenac.
Allergien
NKDA (no known drug allergies)
Vorherige Impfungen
-

VAERS 2583575

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
ND
Alter
1,0
Geschlecht
M
Eingang
17.02.2023
Impfdatum
17.02.2023
Beginn
17.02.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Extra dose administered

Symptomtext

Adverse Event: Mother and Provider were both under the impression that patient was receiving dose #2 in a year of the influenza. Order was placed by Dr.. While RN was entering the vaccines and noticed that patient chart had documented that he had received his 1st dose on 9/19/2022 and 2nd does on 10/31/2022. Patient did receive dose #3 on 02/17/2023. Mother wrote on Vaccine paper work that this was dose #2. Treatment: informed provider, mother and supervisor. Mother was also informed that if patient is to experience abnormal responses to vaccine to call or seek evaluation. Mother stated that "this is miscommunication due to paper work being faxed from previous provider". Mother also stated that "she was under the impression that this was only patients second influenza vaccine" Outcome: When informing Dr. she stated "Patient will be extra protected."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
amoxicillin
Vorherige Impfungen
-

VAERS 2579748

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
DC
Alter
28,0
Geschlecht
M
Eingang
10.02.2023
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

PATIENT RECEIVED INFLUENZA VACCINE DESPITE HAVING RECEIVED AN INFLUENZA VACCINE EARLIER THE SAME DAY FROM ANOTHER FACILITY.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2511397

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
IL
Alter
36,0
Geschlecht
M
Eingang
18.11.2022
Impfdatum
-
Beginn
11.11.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product

Symptomtext

medication ran down the consumer's arm with no reported adverse event; Initial information was received on 11-Nov-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 36 years old male patient and reporter reported that medication ran down the consumer's arm with no reported adverse event while receiving vaccine Influenza quadrival A-B vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 11-Nov-2022, the Influenza quadrival A-B vaccine suspension for injection (intramuscular route in the left arm) (lot UT7716JA and expiration date: 30-Jun-2023) ran down the consumer's arm with no reported adverse event (accidental exposure to product). Action taken: Not applicable. Corrective treatment: Not reported. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2489609

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
WI
Alter
59,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
12.10.2022
Beginn
12.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product

Symptomtext

administered the fluzone QIV-PFS and while the needle was in the patient's skin the medication ran out onto the patients' arm with no reported adverse event; Initial information received on 17-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 59 years old female patient who was administered the fluzone Qiv-Pfs and while the needle was in the patient's skin the medication ran out onto the patients' arm with no reported adverse event , it involved vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications and other vaccines were reported as none On 12-Oct-2022, the patient received a dose of 0.5 ml once (1x) of suspect INFLUENZA QUADRIVAL A-B VACCINE, with an unknown formulation and strength, (lot: UT7716JA ; expiry date: not reported) via intramuscular route in the left deltoid for immunization. It was reported that the caller stated that when she placed the needle on the end of the syringe, she heard a click sound prior to administration. The patient was administered the fluzone qiv-pfs and while the needle was in the patient's skin the medication ran out onto the patient's arm with no reported adverse event (accidental exposure to product) (onset date: 12-Oct-2022; latency : same day) . Large amount of vaccine was leaked Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485013

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
WI
Alter
22,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
12.10.2022
Beginn
12.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product No adverse event

Symptomtext

patients skin the medication ran out onto the patients' arm, with no reported adverse event; Initial information received on 17-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA430802(CLUSTER). This case involves a 22 years old female patient to whom skin the medication ran out onto the patients' arm, with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On 12-Oct-2022, the patient received a 0.5ml 1X(once) dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (strength: unknown, lot UT7716JA and expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for Immunization. On 12-Oct-2022 the patient developed a non-serious event of patients skin the medication ran out onto the patients' arm, with no reported adverse event (accidental exposure to product) (latency: same day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The reporter stated that when she placed the needle on the end of the syringe, she heard a click sound prior to administration. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2480518

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7716JA

gering
Staat
NJ
Alter
41,0
Geschlecht
M
Eingang
17.10.2022
Impfdatum
03.10.2022
Beginn
05.10.2022
Tage bis Beginn
2,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Herpes zoster

Symptomtext

Shingles appeared on right abdomen and back about 48 hours after receiving the vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
10/10 visit to dermatologist confirmed shingles diagnosis
Aktuelle Erkrankungen
-
Vorgeschichte
Kidney Stones
Andere Medikamente
Multivitamins Nortriptyline
Allergien
Lactose
Vorherige Impfungen
-